First National Corp’s Regenxbio RGNX Stock Holding History

First National Corp’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,600	Closed	-$206K	–	360
2019 Q1	$206K	Hold	3,600	–	–	0.09%	136
2018 Q4	$151K	Buy	+3,600	New	+$211K	0.07%	153

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First National Corp's RGNX Position: Q2 2019 in Review

First National Corp sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 3,600 shares — an estimated $206K sold.

First National Corp first reported a position in RGNX in Q4 2018 and held it in 2 quarters. The position peaked at $206K in Q1 2019. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

First National Corp reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
First National Corp sold 3,600 Regenxbio shares in Q2 2019, an estimated $206K.
First National Corp first reported a position in Regenxbio in Q4 2018 and held it in 2 quarters.
First National Corp's Regenxbio position peaked at $206K in Q1 2019.
186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on First National Corp's 13F filing for Q2 2019, filed 30 Jul 2019.